[1]
L. Alghothani, MD and J. Gustin, MD, “Oxycodone-induced neurotoxicity secondary, to concurrent voriconazole use in a patient with cancer”, J of Opioid Management, vol. 13, no. 3, pp. 141–142, May 2017.